BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2871953)

  • 1. Metoclopramide enhances bethanechol-induced pancreatic exocrine secretion of the dog.
    Yamagishi F; Haruta K; Homma N; Iwatsuki K; Chiba S
    Clin Exp Pharmacol Physiol; 1985; 12(6):565-71. PubMed ID: 2871953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of muscarinic receptors in pancreatic exocrine secretion in anesthetized dog.
    Iwatsuki K; Horiuchi A; Yonekura H; Homma N; Haruta K; Chiba S
    Pancreas; 1989; 4(3):339-45. PubMed ID: 2734277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydergine on pancreatic exocrine secretion in the isolated, blood-perfused pancreas of the dog.
    Iwatsuki K; Iijima F; Chiba S
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):328-34. PubMed ID: 6838289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pancreas.
    Iijima F; Iwatsuki K; Chiba S
    Eur J Pharmacol; 1983 Sep; 92(3-4):191-7. PubMed ID: 6313394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion.
    Konturek SJ; Bilski J; Jaworek J; Tasler J; Schally AV
    Proc Soc Exp Biol Med; 1988 Feb; 187(2):241-9. PubMed ID: 2448802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine potentiates secretin-stimulated pancreatic exocrine secretion in the dog.
    Yamagishi F; Homma N; Haruta K; Iwatsuki K; Chiba S
    Eur J Pharmacol; 1985 Dec; 118(3):203-9. PubMed ID: 4085553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil on pancreatic exocrine secretion induced by dopamine, secretin and pancreozymin in the dog.
    Iwatsuki K; Ikeda K; Chiba S
    Clin Exp Pharmacol Physiol; 1982; 9(2):165-72. PubMed ID: 7127915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of secretagogues on pancreatic exocrine secretion in the monkey and the dog.
    Iwatsuki K; Iijima F; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1985; 12(1):67-72. PubMed ID: 4006312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic stimulation and inhibition of pancreatic secretion in alcohol-adapted dogs.
    Schmidt DN; Devaux MA; Biedzinski TM; Sarles H
    Scand J Gastroenterol; 1983 May; 18(3):425-31. PubMed ID: 6687018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between stimulants of exocrine pancreatic secretion in dogs.
    Beglinger C; Grossman MI; Solomon TE
    Am J Physiol; 1984 Feb; 246(2 Pt 1):G173-9. PubMed ID: 6141740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin inhibits secretin-induced canine pancreatic response via a cholinergic mechanism.
    Kuvshinoff BW; Brodish RJ; James L; McFadden DW; Fink AS
    Gastroenterology; 1993 Aug; 105(2):539-47. PubMed ID: 8101500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a synthesized phosphodiesterase inhibitor, ZSY-27, on pancreatic exocrine secretion of the dog.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):487-94. PubMed ID: 3757312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking effects of verapamil on pancreatic exocrine secretion induced by dopamine in the dog.
    Iwatsuki K; Yamagishi F; Homma N; Haruta K; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):145-52. PubMed ID: 3718076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):663-70. PubMed ID: 2433085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol stimulates pancreatic exocrine secretion in the dog.
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S; Oguchi H
    Pancreas; 1989; 4(2):179-84. PubMed ID: 2755942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DN-9693, a synthesized phosphodiesterase inhibitor, on pancreatic exocrine secretion in dogs.
    Iwatsuki K; Horiuchi A; Yonekura H; Haruta K; Homma N; Chiba S
    Jpn J Pharmacol; 1989 Jan; 49(1):77-82. PubMed ID: 2470943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of dopamine on the exocrine pancreatic secretion of the intact dog.
    Delcenserie R; Devaux MA; Sarles H
    Br J Pharmacol; 1986 May; 88(1):189-95. PubMed ID: 2871881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicardipine on pancreatic exocrine secretion in the dog.
    Iwatsuki K; Ikeda K; Chiba S
    Clin Exp Pharmacol Physiol; 1982; 9(6):587-94. PubMed ID: 7166002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of three purine-related compounds on pancreatic exocrine secretion in the dog.
    Yamagishi F; Homma N; Haruta K; Iwatsuki K; Chiba S
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):425-32. PubMed ID: 3742885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.